ARDS / hypoxemic pneumonia Phase 2 trial initiation 1H 2026; early data by year end; market opportunity of ~200,000–300,000 patients annually in ...

Analyst/Investor Day March 31, 2026 12:00 PM EDTCompany ParticipantsAnoori Naughton - Vice President of Investor ...

HONG KONG, March 27, 2026 /PRNewswire/ -- Unisound (09678.HK) announced its audited annual results for the year ended December 31, 2025. As the Company's first annual results announcement since ...

In the topsy-turvy world of aviation, Willie Walsh, the sharpshooting incoming CEO of IndiGo, has a rather peculiar nickname: ...

Crispr Therapeutics AG looks set for 2026 revenue inflection as Casgevy ramps; strong efficacy, undervalued shares, robust ...

McCormick & Company, Incorporated (NYSE:MKC) Q1 2026 Earnings Call Transcript March 31, 2026 McCormick & Company, Incorporated beats earnings expectations. Reported EPS is $0.66, expectations were $0.

MetaOptics Ltd (Catalist: 9MT) ("MetaOptics" or the "Company", and together with its subsidiaries, the "Group") recently ...

Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical-stage biopharmaceutical company developing innovative products focused on the treatment or prevention of gastrointestinal cancers, announces its ...

Can idiosyncratic risk explain the equity premium? We revisit this question using a novel measure of imperfect risk sharing, ...

With contributions from more than 500 companies and 16,000 workers, California is the largest state-level contributor to NASA’s Artemis II. As the space agency sends astronauts on a historic lunar ...

Celcuity Inc. (NASDAQ:CELC) Q4 2025 Earnings Call Transcript March 25, 2026 Celcuity Inc. beats earnings expectations.

Biodexa Pharmaceuticals PLC Stephen Stamp, CEO Fiona Sharp, CFO Tel: +44 (0)29 2048 0180 The Company's lead development programs include eRapa, under development for Familial Adenomatous Polyposis and ...